Cancer stem cells in the human mammary gland and regulation of their differentiation by estrogen

Research output: Contribution to journalArticle


The identification and characterization of normal and breast cancer stem cells have provided a new vision of breast tumorigenesis. Cancer stem cells may be responsible for breast tumor initiation, progression and development of resistance to therapy. Most breast cancers express the estrogen receptor, and several studies have linked long-term estrogen exposure to enhanced breast cancer risk; however, estrogen receptor-positive tumors usually present a better prognosis than estrogen receptor-negative ones. The finding that estrogen reduces the pool of human breast stem cells may explain the more differentiated phenotype observed in estrogen receptor-positive tumors. In this article, our current understanding of the complex role of estrogen in human breast stem cells is discussed in the context of breast malignancy. © 2011 Future Medicine Ltd.

Bibliographical metadata

Original languageEnglish
Pages (from-to)995-1006
Number of pages11
JournalFuture Oncology
Issue number8
Publication statusPublished - Aug 2011